136 related articles for article (PubMed ID: 9201008)
21. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy awareness in a biracial cohort of women aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
Menopause; 1999; 6(3):251-6. PubMed ID: 10486796
[TBL] [Abstract][Full Text] [Related]
23. Estrogen replacement therapy is underutilized among postmenopausal women at high risk for coronary heart disease.
Massey CV; Hupp CH; Kreisberg M; Alpert MA; Hoff C
Am J Med Sci; 2000 Aug; 320(2):124-7. PubMed ID: 10981488
[TBL] [Abstract][Full Text] [Related]
24. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
Wise MR; Stewart DE; Liu P; Abramson BL
CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
[TBL] [Abstract][Full Text] [Related]
25. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
Stehman-Breen CO; Gillen D; Gipson D
Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
[TBL] [Abstract][Full Text] [Related]
26. Use of hormone replacement therapy by postmenopausal women in the United States.
Keating NL; Cleary PD; Rossi AS; Zaslavsky AM; Ayanian JZ
Ann Intern Med; 1999 Apr; 130(7):545-53. PubMed ID: 10189323
[TBL] [Abstract][Full Text] [Related]
27. Correlates of postmenopausal female hormone use among black women in the United States.
Rosenberg L; Palmer JR; Rao RS; Adams-Campbell LL
Obstet Gynecol; 1998 Mar; 91(3):454-8. PubMed ID: 9491877
[TBL] [Abstract][Full Text] [Related]
28. Physician specialty is significantly associated with hormone replacement therapy use.
Levy BT; Ritchie JM; Smith E; Gray T; Zhang W
Obstet Gynecol; 2003 Jan; 101(1):114-22. PubMed ID: 12517655
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement and menopausal symptoms following hysterectomy.
Langenberg P; Kjerulff KH; Stolley PD
Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
[TBL] [Abstract][Full Text] [Related]
30. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
31. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
33. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.
Schneider HP
Int J Fertil Womens Med; 1997; 42 Suppl 2():365-75. PubMed ID: 9397384
[TBL] [Abstract][Full Text] [Related]
34. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population.
Finley C; Gregg EW; Solomon LJ; Gay E
J Community Health; 2001 Feb; 26(1):39-50. PubMed ID: 11297189
[TBL] [Abstract][Full Text] [Related]
35. [Reflections on compliance in menopause hormone replacement therapy].
Berthet J; Tabaste JL; Vendittelli F
Rev Fr Gynecol Obstet; 1995 Dec; 90(12):548-51. PubMed ID: 8677410
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
[TBL] [Abstract][Full Text] [Related]
37. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
Neuner JM; McCarthy EP; Davis RB; Phillips RS
J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Bairey Merz CN; Shaw LJ; Mankad S; Reis SE; Pohost GM; Smith KM; McGorray SP; Cornell CE; Kelsey SF;
J Womens Health (Larchmt); 2004 Apr; 13(3):325-32. PubMed ID: 15130261
[TBL] [Abstract][Full Text] [Related]
39. Racial differences in hormone replacement therapy prescriptions.
Marsh JV; Brett KM; Miller LC
Obstet Gynecol; 1999 Jun; 93(6):999-1003. PubMed ID: 10362170
[TBL] [Abstract][Full Text] [Related]
40. Estrogen replacement therapy use in minority postmenopausal women.
Ganesan K; Teklehaimanot S; Norris K
Ethn Dis; 2000; 10(2):257-61. PubMed ID: 10892833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
